In the treatment of hypertension, beta-blockers primarily achieve their effect by blocking which receptors, leading to reduced heart rate, contractility, and renin release?

Study for the Medical FIDSAP v2 Test. Sharpen your skills with flashcards and multiple-choice questions, complete with hints and explanations. Prepare effectively for your upcoming test!

Beta-adrenergic receptors are the targets. Blocking these receptors, especially the beta-1 subtype in the heart, reduces heart rate and contractility. In the kidneys, beta-1 receptors on juxtaglomerular cells drive renin release; blocking them lowers renin, which decreases the RAAS activity and helps lower blood pressure. The other receptor types don’t explain the combination of slower heart rate, weaker heart contractions, and reduced renin release. Alpha-blockers influence vascular tone but not primarily heart rate or renin; dopamine receptors aren’t the main players in this antihypertensive mechanism; muscarinic receptors are part of parasympathetic signaling and aren’t responsible for these effects.